The company is a high-tech enterprise with Chengdu peptide drug engineering technology research center. The API and preparation workshop has obtained the GMP certificate, and has undertaken the national key project of new drug creation in the 11th Five Year Plan; the API workshop also passed the on-site GMP inspection of FDA in May 2012.
QQ1
QQ2
QQ3